Why the study?
Does adherence to antihypertensive therapy improve blood pressure control in hypertensive out-patients?
Does adherence to antihypertensive therapy improve blood pressure control in hypertensive out-patients?
A large majority of treated hypertensive outpatients have poorly controlled blood pressure, primarily driven by medication non-adherence and obesity.
Answers are grounded in this paper and cite their sources.
Adherence support and obesity management warrant consideration in outpatients; leaves open causal effects without prospective trials.
Objectives: To determine the adequacy of blood pressure (BP) control and level of adherence to pharmacotherapy in hypertensive out-patients.Design: Cross-sectional study.Setting: General medical outpatient clinics at a tertiary referral hospital, Kenyatta National Hospital.Subjects: Hypertensive with at least one documented renewal of prescription. Main outcome measure: Adequacy of BP control and level of adherence by the Hill- Bone score.Results: Of 783 patients screened over a six month period, 575 (73%) met the inclusion criteria and 264 were randomly recruited; 67% were female; mean age was 57.3 years; mean duration of hypertension was 6.75 years (range six months to 31 years);21.6% had normal BMI. Knowledge of lifestyle measures for BP control was weight loss 50%, exercise 54% and salt restriction 80%. Number of antihypertensives prescribed were 35.2% two drugs, 36.6% three drugs and 14.9% on four or more drugs; with drugs class being thiazide diuretics 64.1%, B-blockers 55.7%, calcium channel blockers 55.3% and angiotensin system inhibitors at 50.4%. Sixty eight (26%) had adequate BP control and 114 (58.5%) of those with inadequate BP control had BP of > 160/l00mmHg. Eightyfour (31.8%) of the patients were fully adherent to antihypertensive therapy. Non adherence was not significantly associated with any socio-demographic factors. Poor BP control was significantly associated with non adherence (p=0.006, r2=0.54 SBP, 0.63 DBP), obesity (p=0.03), and increasing number of medications (p=0.012 DBP and 0.038 SBP);other factors included obesity, suboptimal dosing and suboptimal therapeuticcombinations. Conclusion: We document poor BP control in 75% of our treated hypertensive patients and this is largely due to non adherence, with other associated factors being obesity, suboptimal drug combinations and doses.
No takes yet. Share an insight, caveat, or question.
Achieng et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: